SCHEMBL10019863

SCHEMBL10019863

COc1cc(C(C)(C)C)cc(C(C)(C)C)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
TP53 P04637 2/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ACHE P22303 1/20 0.41
MAPT P10636 2/20 0.40
CA9 Q16790 1/20 0.40
RARG P13631 1/20 0.40
RXRA P19793 1/20 0.40
PPARG P37231 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGS2 P35354 2/20 0.39
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR2A P28223 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
GAK O14976 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1754083 0.87 ACHE (0.54) CYP3A4TP53HPGDACHEMAPT
SCHEMBL2947022 0.87 PTGS2 (0.47) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL16070212 0.82 RXRA (0.35) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL13688744 0.81 ALDH1A1 (0.42) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL19351217 0.81 ACHE (0.43) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL12024914 0.81 ACHE (0.48) CYP3A4TP53LMNAACHEMAPT
SCHEMBL14817161 0.81 RARG (0.40) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL24282085 0.79 RARG (0.39) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL15180064 0.79 CA1 (0.55) CYP3A4TP53LMNAHPGDALOX15
SCHEMBL6676891 0.79 PTGS2 (0.42) CYP3A4TP53LMNAHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122025775-A In-situ solidified electrolyte, in-situ solid-state battery and preparation method of in-situ solid-state battery 合肥国轩高科动力能源有限公司 2026-05-12 CN claimed
CN-116973774-A Method for measuring self-discharge of battery, redox electrolyte and application 上海瑞浦青创新能源有限公司 2023-10-31 CN claimed
CN-113054253-B Overcharge-proof electrolyte of lithium ion battery 江西格林德能源有限公司 2022-08-12 CN claimed
CN-114883677-A Lithium pre-preparing method for lithium ion battery 上海瑞浦青创新能源有限公司 2022-08-09 CN claimed
CN-122025775-A In-situ solidified electrolyte, in-situ solid-state battery and preparation method of in-situ solid-state battery 合肥国轩高科动力能源有限公司 2026-05-12 CN disclosed
US-20240136585-A1 ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS APPLE INC. (US) 2024-04-25 US disclosed
US-11916198-B2 Fast-charging lithium ion batteries with electrolytes that do not react on the anodes StoreDot Ltd. (IL) 2024-02-27 US disclosed
CN-117480680-A Separator, electrochemical device, and electronic apparatus 宁德新能源科技有限公司 2024-01-30 CN disclosed
US-11881558-B2 Electrolytes for lithium-containing battery cells APPLE INC. (US) 2024-01-23 US disclosed
CN-116973774-A Method for measuring self-discharge of battery, redox electrolyte and application 上海瑞浦青创新能源有限公司 2023-10-31 CN disclosed
CN-116914244-A High concentration lithium ion electrolyte for battery cells 苹果公司 2023-10-20 CN disclosed
US-20230335785-A1 HIGH-CONCENTRATION LITHIUM-ION ELECTROLYTES FOR BATTERY CELLS APPLE INC. (US) 2023-10-19 US disclosed
US-20150280259-A1 POLYOXOMETALATE ACTIVE CHARGE-TRANSFER MATERIAL FOR MEDIATED REDOX FLOW BATTERY NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC 2015-10-01 US disclosed
US-20150280259-A1 POLYOXOMETALATE ACTIVE CHARGE-TRANSFER MATERIAL FOR MEDIATED REDOX FLOW BATTERY NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC 2015-10-01 US disclosed
US-20150094240-A1 CHEMICAL COMPOUNDS RESMAN AS (NO) 2015-04-02 US disclosed
US-8101302-B2 Redox shuttles for high voltage cathodes 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-24 US disclosed
CN-102005619-A Redox couple for lithium ion battery overcharge-resistant mixed additive HEFEI LI XIN ENERGY MATERIALS CO LTD 2011-04-06 CN disclosed
US-20090286162-A1 REDOX SHUTTLES FOR HIGH VOLTAGE CATHODES 3M INNOVATIVE PROPERTIES COMPANY 2009-11-19 US disclosed
US-7592332-B2 Cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-09-22 US disclosed
US-20090023701-A1 Cytokine Inhibitors AUNGST RONALD A 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023701-A1 Cytokine Inhibitors IL1B, TNF, IL1A CYP3A4 1555/4885TP53 3085/4885LMNA 4112/4885
US-20150094240-A1 CHEMICAL COMPOUNDS PTGES, PTGIS, PTGFR CYP3A4 921/4885TP53 23/4885LMNA 3760/4885
US-20240136585-A1 ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS CEL, CA3, SLC9B2 CYP3A4 2881/4885TP53 479/4885LMNA 288/4885
US-11881558-B2 Electrolytes for lithium-containing battery cells CEL, CA3, SLC9B2 CYP3A4 2881/4885TP53 479/4885LMNA 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.